Nivel 5 ATC
L04AA23 - Natalizumab
3 medicamente în această clasă
Medicamente (3)
| Nume comercial | DCI | Concentrație | Producător |
|---|---|---|---|
| TYRUKO 300 mg | Natalizumabum | 20mg/ml | Sandoz Gmbh - Austria |
| TYSABRI 150mg | Natalizumabum | 150mg | Biogen (denmark) Manufacturing Aps - Danemarca |
| TYSABRI 300mg | Natalizumabum | 20mg/ml | Biogen (denmark) Manufacturing Aps - Danemarca |
Substanțe active în L04AA23
Clase înrudite
L04AA02 muromonab-CD3 L04AA03 Antilymphocyte Immunoglobulin (horse) L04AA04 Antithymocyte Immunoglobulin (rabbit) L04AA06 Mycophenolic Acid L04AA10 Sirolimus L04AA13 Leflunomide L04AA15 Alefacept L04AA18 Everolimus L04AA19 Gusperimus L04AA21 Efalizumab L04AA22 Abetimus L04AA24 Abatacept L04AA25 Eculizumab L04AA26 Belimumab L04AA27 Fingolimod L04AA28 Belatacept L04AA29 Tofacitinib L04AA31 Teriflunomide L04AA32 Apremilast L04AA33 Vedolizumab L04AA34 Alemtuzumab L04AA35 Begelomab L04AA36 Ocrelizumab L04AA37 Baricitinib L04AA38 Ozanimod L04AA39 Emapalumab L04AA40 Cladribine L04AA41 Imlifidase L04AA42 Siponimod L04AA43 Ravulizumab L04AA44 Upadacitinib L04AA45 Filgotinib L04AA46 Itacitinib L04AA47 Inebilizumab L04AA58 (l04aa58)